Top Markets
Coin of the day
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc.

NuGenerex Immuno-Oncology, Inc.

NUGX
Classement en actions #41797
NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating... NuGenerex Immuno-Oncology, Inc. is an oncology firm committed to treating cancer through the strategic modulation of the immune system. The company's development pipeline includes a range of immunotherapeutic products and vaccines. Notably, it is advancing AE37, a peptide immunotherapeutic vaccine, which is currently undergoing Phase II clinical studies for metastatic triple-negative breast cancer. Founded in 1993 and headquartered in Miramar, Florida, the entity was formerly named Antigen Express, Inc. NuGenerex Immuno-Oncology, Inc. operates as a subsidiary of Generex Biotechnology Corporation.
Prix de l'action
$0.0001
Dernière synchronisation: 2023-05-22
Capitalisation boursière
$10.03K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange NuGenerex Immuno-Oncology, Inc. (NUGX)

Catégorie

Historique du prix de l'action pour NuGenerex Immuno-Oncology, Inc. (NUGX)
Prix de clôture le plus élevé : $0.00 le 2023-05-01

Prix de clôture le plus bas : $1.44 le 2021-03-01
Historique du prix de l'action de NuGenerex Immuno-Oncology, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 75.00%
2022 -98.81%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.34%
KR